Brief: Phytanix Bio to List on Nasdaq Via $58 Mln SPAC Deal

Chain Bridge I

22/07/2024 22:51

July 22 (Reuters) - Phytanix Bio and Chain Bridge I:
    * CHAIN BRIDGE I TO ACQUIRE PHYTANIX BIO, CREATING A NEW
PUBLIC
COMPANY FOCUSED ON DEVELOPING NEXT GENERATION CANNABINOID AND
CANNABINOID-LIKE MEDICINES
    * CHAIN BRIDGE I: TRANSACTION REFLECTS A PRE-DEAL VALUATION
OF $58
MILLION FOR PHYTANIX BIO
    * CHAIN BRIDGE I - COMBINED COMPANY TO BE LISTED ON NASDAQ
CAPITAL
MARKETS UNDER TICKER "PHYX"
    * CHAIN BRIDGE I - BARRETT EVANS WILL SERVE AS CEO OF
COMBINED
COMPANY
    * CHAIN BRIDGE I: NEW COMPANY WILL BE LED BY PHYTANIX BIO'S
FOUNDERS COLIN STOTT, DOMINIC SCHILLER AND BARRETT EVANS
    * CHAIN BRIDGE I: BUSINESS COMBINATION IS NOT SUBJECT TO A
MINIMUM
CASH CONDITION

Source text for Eikon:  ID:nGNX5n0y78 
Further company coverage:  CBRG.O 

 ((Reuters.Briefs@thomsonreuters.com;))